SNWV Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 15:55):

Stats
Today's Volume	644 500
Average Volume	339 720
Market Cap	25.09M
EPS	$0 ( 2024-04-01 )
Next earnings date	( $0 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.730
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Sorensen Peter	Buy	0
2023-12-30	Manchester Management Co Llc	Buy	0	Future Advance Convertible Promissory Note
2023-12-30	Manchester Management Co Llc	Buy	2 500 000	Common Stock Purchase Warrant
2023-12-30	Manchester Management Co Llc	Buy	2 500 000	Common Stock Purchase Warrant
2023-12-30	Manchester Management Co Llc	Buy	2 500 000	Common Stock Purchase Warrant

INSIDER POWER
88.13
Last 94 transactions
Buy: 194 230 063 \| Sell: 31 191 675

SANUWAVE Health, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

SANUWAVE Health, Inc. Financials

Annual	2023
Revenue:	$20.40M
Gross Profit:	$13.61M (66.73 %)
EPS:	$-0.0325

Q4	2023
Revenue:	$6.99M
Gross Profit:	$4.65M (66.43 %)
EPS:	$0.0160

Q3	2023
Revenue:	$4.95M
Gross Profit:	$3.54M (71.49 %)
EPS:	$-0.0265

Q2	2023
Revenue:	$4.68M
Gross Profit:	$3.47M (74.29 %)
EPS:	$-0.0125

Financial Reports:

No articles found.

SANUWAVE Health, Inc.

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.